Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Feb 24, 2023 9:52am
140 Views
Post# 35303081

RE:"Nearing 90 patient interim enrollment"

RE:"Nearing 90 patient interim enrollment"Hey AP

Your post is inconsistent with the "Key Pout" sign hanging on the door, of late.  Is the negativity of late correlated to the Option season?  hmmmm?  BS usually make a significant appearance when there is a need to lower the price for the short term (which inevitably creates a buying opportunity for those paying attention and that have dry powder and patience)

Isn't it interesting that that public personae of the Company is as a bumbling, soon to go bankrupt, lifestyle company (perpetuated by various characters here)

Yet it's very possible that they are 86% of the way there.  (179+52)/(179+90)

Most new medical treatments (drugs or device) take more than $ 1B to bring to market (with FDA approval).  Spectral will likely complete approval for this life-saving Sepsis treatment (afflicting  50 MILLION worldwide and killing almost 10 MILLION annually) by spending a grand total of under $ 200 million Canadian $ !  Quite a feat when you look at the big picture.

Your $ 5 is likely light (using Spectral's numbers).  What multiple did you use?

MM
<< Previous
Bullboard Posts
Next >>